Human immunodeficiency virus type 1 (HIV-1) is classified into different phylogenetic subtypes, with subtype C representing more than half of the novel infections globally. However, there are relatively few subtype C envelopes available for study. We amplified 18 unique env genes from 13 patients who were infected with subtype C HIV-1 in six African countries and in Scotland to create replication-competent viruses. These envelopes are phylogenetically diverse across the subtype C spectrum, and have on average more N-linked glycosylation sites and slightly longer variable loops than previously described C envelopes. We found that CCR3 coreceptor usage is less prevalent in subtype C than in subtype B viruses, and these envelopes have varied sensitivity to neutralization. The subtype C chimeric viruses generated in this study will be useful for evaluating the breadth of neutralizing antibodies and other entry inhibitors.
Subtype C human immunodeficiency virus type 1 (HIV-1) accounts for .50 % of all new infections worldwide, and is the most prevalent subtype in sub-Saharan Africa, South Asia and Brazil (UNAIDS/WHO, 2009) . Although useful panels of subtype C primary isolates (Brown et al., 2005; Bures et al., 2002; Fernandez-Garcia et al., 2009) and pseudoviruses (Gray et al., 2006; Li et al., 2006b ) have been developed, more need to be characterized due to the diversity of the envelope gene, env, within this subtype. For instance, the standard reference panel of subtype C envelopes (Envs) included isolates from only two African countries, Zambia and South Africa (Li et al., 2006b) . Here, we analysed Envs from infections acquired in six African countries and from Scotland, UK. Our replicationcompetent viruses with new Envs represent a diverse range of contemporary subtype C isolates for which we have determined coreceptor usage and sensitivity to neutralizing antibodies.
Plasma samples were obtained from 13 HIV-1 subtype C infected, treatment naive individuals diagnosed in Scotland through the National Surveillance System (Yirrell et al., 2004) . The undisclosed patients' origins and viral loads are presented in Supplementary Table S1 (available in JGV Online). Nine samples were derived from individuals infected in Africa and four from individuals infected in Scotland. The subtype was determined by gag sequence typing. Viral envs (gp160 and gp120) were amplified directly from plasma viral RNA extracted with QIAamp Viral RNA Mini kit (Qiagen) using primers shown in Supplementary Table S2 (available in JGV Online) and Titan One Tube RT-PCR kit (Roche Applied Sciences).
Env genes were cloned into pHXB2Denv (gp120) or the C2 cassette (gp160), which enables production of replicationcompetent chimeric viruses (McKeating et al., 1996; Zheng & Daniels, 2001) . Therefore, unlike the previous panels of subtype C envs, those in this panel are uniquely able to spread infection. Viruses were generated by transfection of 293T cells and clones that yielded infectious progeny [¢1000 focus forming units (f.f.u.) ml 21 on NP2/CD4/ CCR5 or NP2/CD4/CXCR4 cells] were sequenced to exclude identical clones. A total of 18 unique chimeric viruses were generated and the GenBank accession numbers of the cloned envs are shown in Supplementary Table S1 . The deduced amino acid sequences were aligned with the consensus subtype C sequence from the Los Alamos National Laboratory (LANL) HIV database ( Supplementary  Fig. S1 , available in JGV Online). The mean number (26.7) of potential N-linked glycosylation sites (PNLGS) in this panel of Envs is significantly higher (Student's t-test P,0.001) than the mean number (24.4) in the standard reference panel (Li et al., 2006b) , and the mean lengths of the variable loops were all longer than the consensus C sequence (Supplementary Table S3 , available in JGV Online). Fig. 1 shows a maximum-likelihood phylogenetic tree constructed according to the GTR+I+G model of nucleotide substitution with 1000 bootstrap replications to depict the phylogenetic relationship between the 18 env sequences in this panel, the 12 env clones in the subtype C standard reference panel (Li et al., 2006b) , and 210 HIV-1 subtype C env sequences extracted from the LANL HIV database. The cloned env sequences in this panel were spread across the 210 subtype C sequences from the LANL database and are therefore highly diverse. However, the envs cloned from the Scottish patients were closely related and might belong to a single transmission network. As they clustered closely to the Mozambique isolate CB7 (bootstrap support .90 %), this subclade might have been introduced from that region of Africa.
The coreceptor utilization of the cloned Envs was evaluated on the NP2 and U87 indicator cell lines expressing CD4 alone, or CD4 in combination with either CCR5, CXCR4, CCR1, CCR2b, CCR3, CCR8 or APJ (Deng et al., 1996; Soda et al., 1999) . Infection was detected by p24 immunostaining 48 h post-inoculation and the number of infectious foci were counted (Aasa-Chapman et al., 2006a) . Table 1 shows that the cloned viruses were CCR5-tropic, as is typical of subtype C viruses regardless of the stage of infection (Abebe et al., 1999; Bjorndal et al., 1999; Cecilia et al., 2000; Cilliers et al., 2003; Li et al., 2006a; Morris et al., 2001; Zhang et al., 2006) , although one virus (C344) was R5/X4 dual-tropic. The CCR5-tropism of the viruses reported here matched the V3-loop based algorithm, which stipulates that a high-positive charge of V3 and basic residues at positions 306, 321 and/or 322 is required for CXCR4 tropism (Cardozo et al., 2007; Xiao et al., 1998) . Alternative coreceptors (CCR1, CCR2b, CCR3, CCR8 and APJ) were tested but efficient cellular entry was rare, in agreement with other recently published studies on coreceptor usage by subtype C Envs except that we recorded lower use of APJ (Isaacman-Beck et al., 2009; Nedellec et al., 2009) . Only 1/18 Envs yielded a notable level of infection on CCR1-, 2/18 on CCR8-and 4/18 on CCR3-expressing cells (Table 1 ; the cut off for significant infection was set to ¢10 % of the level on CCR5-expressing indicator cells). The R5/X4-dual tropic virus was unusual in that it could use most of the coreceptors tested (CCR5/R3/R8/R2b/CXCR4).
The proportion of subtype C viruses studied here that are able to use CCR3 efficiently was considerably lower than our previous findings on subtype B Envs, for which .80 % of the Envs amplified directly from blood samples could utilize CCR3 efficiently (Aasa-Chapman et al., 2006a). Furthermore, the median level of CCR3 usage (measured as f.f.u. ml
21
) compared with CCR5 for the Envs cloned in this study was only 3.9 % (Table 1) , compared with 47 % for the subtype B viruses previously studied (AasaChapman et al., 2006a) . This indicates that there may be a subtype-associated difference in CCR3 usage, and we corroborated this finding by measuring the CCR3 usage of viruses in the subtypes B and C Env reference panels (Li et al., 2005 (Li et al., , 2006b ). The median value of CCR3 usage compared with CCR5 in the panel of 12 subtype B Envs was 9.8 % (range of 0.2-81 %), in contrast to a much lower median value of 0.05 % (range of 0.01-0.61 %) in the panel of 12 subtype C Envs (Supplementary Table S4a , b, available in JGV Online).
HIV-1 determinants for CCR3 tropism have been mapped to the variable V1/V2 and V3 loops of gp120 (Choe et al., 1996; Hoffman et al., 1998 , and the lack of CCR3 tropism was associated with the presence of the negatively charged Glu 440 in 5/12 viruses. In contrast, residue Asn 448 was broadly conserved among the subtype C Envs, and in no case substituted with a negatively charged residue. The only Env clone from the subtype B panel with minimal tropism for CCR3 (,1 %) was also the only clone with a negatively charged amino acid at residue 440 (Glu 440 ), whereas residue Asn 448 was uniformly conserved. These data substantiate the link between Glu 440 and compromised CCR3-mediated entry, extending it to subtype C viruses, but also highlight that other determinants for CCR3 usage are yet to be identified.
It is possible that the difference in CCR3-usage by subtype B and C viruses may affect neuropathogenesis, which appears to be more common among treatment-naive subtype B than subtype C-infected individuals (Rao et al., 2008) . Additionally, CCR3 usage has been shown to be important for HIV-1 infection of microglia by many subtype B isolates, which may have implications for HIVassociated dementia (Agrawal et al., 2009) .
Virus neutralization was assayed on TZM-bl cells using the Luc reporter as described previously (Montefiori, 2004) . The neutralization phenotype of the 18 replicationcompetent subtype C viruses was assessed with four wellcharacterized broadly cross-neutralizing human monoclonal antibodies (mAbs), recombinant soluble CD4 (sCD4) and two heterologous patient sera QC1 and QC2 from individuals infected with subtype B (Table 2) .
Most clones were neutralized by sCD4 at concentrations below 10 mg ml 21 , but three of the virus clones (CA6, C281 and C28.g) were resistant to sCD4 neutralization, which is Novel subtype C HIV-1 envelopes cloned from plasma uncommon for subtype C viruses. The gp120 mAbs tested were b12, targeting an epitope overlapping the CD4-binding site (Zhou et al., 2007) , and 2G12, recognizing a mannose cluster on the outer domain of gp120 (Calarese et al., 2003; Sanders et al., 2002; Scanlan et al., 2002) . mAb b12 neutralized six (30 %) of the isolates, which was lower than the 56-67 % reported in other studies on subtype C viruses (Binley et al., 2004; Bures et al., 2002; Gray et al., 2006; Li et al., 2006b) . Virus C392 was particularly sensitive to b12, with an IC 50 value of ,0.02 mg ml
, and was also sensitive to sCD4 (IC 50 2.3 mg ml
). All the subtype C viruses tested here, except for C28.d, were resistant to 2G12. Similar broad resistance to 2G12 has been reported for other subtype C viruses (Binley et al., 2004; Bures et al., 2002; Gray et al., 2006; Wu et al., 2006) , which was usually linked to mutations of epitope-associated PNLGS. Although C28.g (a clone derived from the same patient as the 2G12-sensitive C28.d) encodes all 2G12-associated PNLGS, it is resistant to 2G12 neutralization, indicating that the context in which the PNLGS are encoded can influence recognition by 2G12.
Regarding gp41 neutralization epitopes, mAbs 2F5 and 4E10 recognize adjacent epitopes in the membraneproximal external region (MPER) of gp41 (Muster et al., 1993; Zwick et al., 2001) . Only the gp160 chimeras were tested for sensitivity to 2F5 and 4E10, as the epitopes for these mAbs are encoded by the vector backbone in the gp120-chimeras. None of the five subtype C gp160 Envs were recognized by 2F5, because they lacked the core DKW motif in the MPER (Binley et al., 2004; Muster et al., 1993; Ofek et al., 2004) , which was substituted with DSW and in agreement with the consensus for subtype C. However, all five gp160 clones were neutralized by 4E10 because its core WFXI motif (Binley et al., 2004; Cardoso et al., 2005; Zwick et al., 2001 ) was conserved.
All 18 viruses were neutralized by patient serum QC1, and 10/18 clones were also sensitive to QC2. A positive score *Clones marked with an # are gp160 env clones. DViruses were classified as dual-(or multi-) tropic if their titres with alternative coreceptors were within 1 log 10 of the titre obtained with the dominant coreceptor line. Similar titres were obtained with NP2/CD4/CCR5 and U87/CD4/CCR5 cells (data not shown). dMedian infectivity of NP2/CD4/CCR3 cells compared with NP2/CD4/CCR5, as a percentage. Values of ,1 and ,3 % were set to 0 % for the calculation.
Novel subtype C HIV-1 envelopes cloned from plasma was set at an IC 50 value two times greater than the IC 50 obtained with sera from HIV-1 seronegative individuals (normal human sera, NHS). Very limited virus inactivation was observed with NHS (IC 50 ,10-24, reciprocal serum dilution), thus indicating good specificity in the assay. Five clones (C261, C291, C344, C361 and C381) were remarkably sensitive to neutralization by the heterologous patient sera, In this study, 18 unique env clones of HIV-1 representing a genetically diverse set within subtype C were derived from plasma samples sourced from 13 individuals who were infected in six different African countries and in Scotland, UK. Three chimeric viruses (C27.b, C28.g and C38.22, catalogue numbers: ARP2131.1, ARP2131.2 and ARP2131.3) have been deposited in the Centre for AIDS Reagents at the National Institute of Biological Standards & Control of the Health Protection Agency, UK, to allow access by the HIV/ AIDS research community. These gp160 clones are genetically diverse and differ from those in the subtype C standard reference panel. They also display different degrees of sensitivity to neutralization by sCD4 and b12, and add to the Tier 1 and 2 subtype C viruses available for study. These Envs were included in our analyses of llama antibody fragments that target the CD4-binding site of gp120 (Forsman et al., 2008; Koh et al., 2010) , and may be useful reagents for characterizing HIV-1 entry inhibitors and for studies of immune responses to HIV vaccine candidates. providing NP2 and U87 cells expressing coreceptors; D. Montefiori for providing TZM-bl cells and env clones through the Comprehensive Antibody Vaccine Immune Monitoring Consortium 
